InvestorsHub Logo

chemist72

11/15/17 10:15 AM

#24623 RE: chemist72 #24621

BTW, other interesting comments are as follows:

During the three months ended September 30, 2017, the Company issued 870,000,000 common shares at deemed prices ranging from $0.00030 to $0.00038 per share upon conversion of the convertible promissory notes and accrued interest, valued at $292,500.

In case some of those shares haven't been sold yet, they will still yield a profit with the current bid at $.0004; furthermore, the following info is provided regarding financing activity in Oct. and Nov. 2017:

In October and November 2017, the Company issued 401,459,699 common shares at deemed prices ranging from $0.000225 to $0.00030 per share upon conversion of the convertible promissory notes and accrued interest, valued at $109,152.